kjhrx.bsky.social
@kjhrx.bsky.social
November 11, 2025 at 9:15 PM
In Uganda, 10.1% of children and 8.6% of adults on dolutegravir (DBRs) showed HIV drug resistance, up from 6.6% and 4.4% in 2022. 559 of 857 specimens were genotyped. 📈🦠##idsky
Emergence of acquired HIV drug resistance among individuals receiving dolutegravir-based antiretroviral therapy in Uganda: A national laboratory-based survey 2023
As dolutegravir-based regimens (DBRs) become more widely used and patients remain on treatment longer, cases of virological failure remain rare. This study presents findings from the second annual round of acquired HIV drug resistance (HIVDR) surveillance in Uganda, among individuals with viral non-suppression (≥1,000 copies/mL) receiving DBRs for ≥ 9 months. The first round was conducted from February to April 2022.MethodsThis nationally representative cross-sectional survey analysed randomly selected remnant plasma and dried blood spot specimens collected between April and July 2023 from the Central Public Health Laboratories. Genotyping targeted the integrase, protease, and reverse transcriptase regions of the HIV-1 pol gene, resistance was analysed using the Stanford HIVDR Database. Weighted HIVDR prevalence and 95% confidence intervals (CI) were calculated for children (0–14 years) and adults (≥15 years).ResultsOut of 857 specimens tested, 400 (46.7%) were from children and 457 (53.3%) from adults. Median ages were 11 years for children and 36 years for adults. Median time on DBRs was 1.9 years for children and 2.4 years for adults. 559 (65.2%) specimens were successfully genotyped. The prevalence of DTG resistance was 10.1% (95% CI: 6.4%–13.9%) in children and 8.6% (95%CI: 3.9%–13.3%) in adult, higher than the first-round with a prevalence of 6.6% (95%CI: 3.5%–9.6%) and 4.4% (95%CI: 0.7%–7.1%), respectivelyConclusionsThe increase in DTG resistance among both children and adults highlights the need to strengthen adherence and enhance early identification of individuals at risk of HIVDR through novel and existing programmatic interventions.
academic.oup.com
November 6, 2025 at 6:13 PM
November 6, 2025 at 6:13 PM
1 in 3 #UTIs are now drug-resistant! #AMR

According to the 2025 Global Antibiotic Surveillance Report from @who.int, 1 in 6 bacterial infections globally are drug-resistant.

Learn more: www.who.int/publications...
October 28, 2025 at 2:09 PM
🔥from #IDWeek🔥 from Dr. Ali Dehghani, et al. #IDSky

Adults >=50 w/ shingles vaccine have a:
- 50% lower risk of dementia caused by blood flow problems
- 27% lower risk of blood clots
- 25% lower risk of heart attack or stroke.
- 21% lower risk of premature death

www.healthday.com/health-news/...
Shingles Vax Protects Against Heart Disease, Dementia, Death
MONDAY, Oct. 20, 2025 (HealthDay News) — The shingles vaccine does more than just protect middle-aged folks and seniors against maddening rashes, a new study sa
www.healthday.com
October 20, 2025 at 4:28 PM
A massive study of 100M+ people shows:
🔁 VZV reactivation(shingles)= higher dementia risk

💉 Shingles vaccine = lower dementia risk
Protect your nerves and your neurons. #PublicHealth #VaccinesSaveLives
www.nature.com/articles/s41...
#BlueSky #amedSky #SciSky #IDSky #NeuroSky #EMSky #NurseSky
October 13, 2025 at 2:58 PM
October 13, 2025 at 2:55 PM
The Centers for Disease Control and Prevention has reported 1,514 measles cases as of Sept. 24, the highest number of annual cases since the United States declared measles eliminated in 2000.

Gift link.

www.nytimes.com/interactive/...
Tracking U.S. Measles Outbreaks (Gift Article)
As new cases are reported, our maps show the spread of the virus.
www.nytimes.com
September 30, 2025 at 7:25 PM
Vaccinations are so important to protect ourselves and our community!
#PITT_IDFALL2025
September 30, 2025 at 7:21 PM
Eravacycline: a further weapon against NDM-producing Klebsiella pneumoniae? The case of a man with surgical site infection successfully treated with eravacycline plus ceftazidime/avibactam plus aztreonam
doi.org/10.1093/jaca...
#JACAMRNews #IDSky #AMRrounds @wwrighid.bsky.social
September 25, 2025 at 5:05 PM
You’ve heard of #Lymedisease, but have you ever seen the bacteria that causes it? 🦠 Borrelia burgdorferi, the spiral-shaped culprit transmitted by ticks, swims with a creepy wriggling motion and uses #chemotaxis to navigate. Both fascinating... and disgusting #Microsky 🧪 #IDsky @shawlab.bsky.social
September 24, 2025 at 12:29 PM
Herd immunity is essential to protect communities. #PITT_ID25
Tragic and alarming: From the states collecting data, 68% of U.S. counties and jurisdictions have immunization rates below 95% for the MMR vaccine — the level of herd immunity that is required to stop the spread of measles.
September 24, 2025 at 12:29 PM
Innsbruck and Amsterdam researchers tested human airway models and found that the blood thinner enoxaparin blocked influenza infection, reduced inflammation, and protected cells, suggesting it could work as a nasal spray prophylactic.

academic.oup.com/jid/advance-...
September 24, 2025 at 12:29 PM
Interesting! #PITT_ID25
ICYMI: LPOXY Therapeutics, Inc secures $28M to initiate STOP-Cdiff, a pivotal phase 3 trial of SIDIPREV, a first-in-class non-antibiotic therapy aimed at preventing C. difficile infection, a leading US healthcare–associated threat #IDsky #MEDsky

Read more: www.contagionlive.com/view/lpoxy-s...
September 24, 2025 at 12:29 PM
September 24, 2025 at 12:28 PM
Frightening news for our public health. #PITT_ID25
Florida will end ALL vaccination mandates.

This is bad.
#IDSky
September 24, 2025 at 12:28 PM
You’ve heard of #Lymedisease, but have you ever seen the bacteria that causes it? 🦠 Borrelia burgdorferi, the spiral-shaped culprit transmitted by ticks, swims with a creepy wriggling motion and uses #chemotaxis to navigate. Both fascinating... and disgusting #Microsky 🧪 #IDsky @shawlab.bsky.social
September 24, 2025 at 12:27 PM